Document:

EX-10.2

AGREEMENT

THIS AGREEMENT, effective as of November 11, 2015 (“Effective Date”) by and between CME Group
Inc. (“Employer” or “CME”), a Delaware corporation, having its principal place of business at 20
South Wacker Drive, Chicago, Illinois, and Phupinder Gill (“Executive”).

R E C I T A L S:

WHEREAS, Employer wishes to continue to retain the services of Executive in the capacity of
Chief Executive Officer, upon the terms and conditions hereinafter set forth and Executive wishes
to continue such employment; and

WHEREAS, Employer and Executive wish to supersede the Agreement entered into by them and
effective as of February 5, 2014 and agree to be bound by the terms of this Agreement.

NOW, THEREFORE, in consideration of the mutual promises contained herein, the parties mutually
agree as follows:

	1.	 	Employment. Subject to the terms of the Agreement, Employer hereby agrees to employ
Executive during the Agreement Term (as hereinafter defined) as Chief Executive Officer and
Executive hereby accepts such employment. Executive’s duties shall include, but not be
limited to, the performance of all duties associated with managing and/or overseeing the day
to day functions of CME-wide operations (but not including Government Relations, Corporate
Marketing and Communications, which shall be the direct responsibility of Employer’s Executive
Chairman and President) and such other duties as are the responsibility of Employer’s chief
executive officer pursuant to applicable law or regulation. Executive shall report to
Employer’s Executive Chairman and President, with approval of Executive’s annual goals,
performance review and retention or termination by Employer’s Board of Directors (the
“Board”). Executive will provide such business and professional services in the performance
of his duties that are consistent with Executive’s position, and as shall reasonably be
assigned to him by the Executive Chairman and President or the Board. Executive shall devote
his full time, ability and attention to the business of Employer during the Agreement Term.
During the Agreement Term, Executive shall comply with the Company’s share ownership
guidelines as in effect from time to time. To the extent provided in Employer’s by-laws,
Executive will be nominated as a member of the Board during the Agreement Term.

Nothing in the Agreement shall preclude Executive from participating in the affairs of any
governmental, educational or other charitable institution and serving as a member of the
board of directors of a corporation, except for a competitor of Employer, provided Executive
notifies the Governance Committee of the Board prior to his participating in any such
activities and as long as the Governance Committee does not determine that any such
activities interfere with or diminish Executive’s obligations under the Agreement.
Executive shall be entitled to retain all fees and other compensation derived from such
activities, in addition to the compensation and other benefits payable to him under the
Agreement, but shall disclose such fees to Employer.

	2.	 	Agreement Term. Executive shall be employed hereunder for a term which expires on
December 31, 2019 (“Agreement Term”). The Agreement Term shall be subject to early
termination as set forth herein.

	3.	 	Compensation.

	 	(a)	 	Annual Base Salary. During the Agreement Term, Employer shall pay to
Executive a base salary at a rate not less than $1,000,000 per year (“Base Salary”),
payable in accordance with the Employer’s normal payment schedule. As of January 1,
2016, during the Agreement Term, Executive’s Base Salary shall increase to $1,250,000
per year.

	 	(b)	 	Bonuses. During the Agreement Term, Executive shall be eligible to
participate in the Employer’s Annual Incentive Plan (the “AIP”) as in effect from time
to time. Commencing as of January 1, 2016, Executive’s target bonus opportunity under
the AIP shall be 150% of the base salary paid in the plan year. For the avoidance of
doubt, the Compensation Committee of the Board retains the discretion to determine the
actual bonus amount to be paid for each plan year, subject to the terms of the AIP.

	 	(c)	 	Equity Compensation. During the Agreement Term, Executive shall be
eligible to participate in the CME Group Inc. Amended and Restated Omnibus Stock Plan
(“Plan”) as in effect from time to time. As of January 1, 2016, Executive’s target
grant date value opportunity under the Plan shall be 250% of Base Salary. For the
avoidance of doubt, the Compensation Committee of the Board retains the discretion to
determine the actual grant date value for each plan year, subject to the terms of the
Plan.

	4.	 	Change of Control Provisions. In the event of a “Change of Control” (as defined in
the Plan) that occurs prior to Executive’s termination of employment with the Employer, all
options and time-vesting restricted shares previously granted to Executive, whether during the
Agreement Term or otherwise, will have vesting accelerated so as to become 100% vested;
provided, however that any awards granted following the Effective Date the vesting of which is
contingent upon the attainment of performance goals shall have the continued employment
requirement applicable to such award waived and shall become vested or shall be forfeited
solely based on the actual performance measured over the full performance term (unless a more
favorable treatment is provided in the agreement evidencing the particular award or applies to
the award pursuant to the operation of the applicable plan under which the award was granted,
in which case such more favorable treatment will apply). Thereafter, the options will
continue to be subject to the terms, definitions and provisions of the Plan and any related
option agreement. If Executive is involuntarily terminated without Cause within sixty (60)
days prior to a Change of Control, all unvested options and time-vesting restricted shares
which would have been outstanding had Executive been employed on the date of Change of Control
become 100% vested; provided, however that any awards granted following the Effective Date the
vesting of which is contingent upon the attainment of performance goals shall have the
continued employment requirement applicable to such award waived and shall become vested or
shall be forfeited solely based on actual performance measured over the full performance term
(unless a more favorable treatment is provided in the agreement evidencing the particular
award or applies to the award pursuant to the operation of the applicable plan under which the
award was granted, in which case such more favorable treatment will apply). Employer shall
cause the Plan and all future grants thereunder to permit Executive to transfer awards granted
thereunder for estate and tax planning purposes to members of Executive’s immediate family or
to one or more trusts for the benefit of such family members, partnerships in which such
family members are the only partners, or corporations in which such family members are the
only stockholders.

	5.	 	Benefits. Executive shall be entitled to insurance, vacation and other employee
benefits commensurate with his position in accordance with Employer’s policies for executives
in effect from time to time. Executive acknowledges receipt of a summary of Employer’s
employee benefits policies in effect as of the date of this Agreement.

	6.	 	Expense Reimbursement. During the Agreement Term, Employer shall reimburse
Executive, in accordance with Employer’s policies and procedures, for all proper expenses
incurred by him in the performance of his duties hereunder.

	7.	 	Termination. Executive’s employment as Chief Executive Officer, shall terminate upon
the occurrence of any of the following events. Upon any termination of Executive’s employment
for any reason, Executive agrees to resign and shall be deemed to have resigned as a member of
the Board, if he then is a member of the Board.

	 	(a)	 	Death. Upon the death of Executive, this Agreement shall automatically
terminate and all rights of Executive and his heirs, executors and administrators to
compensation and other benefits under this Agreement shall cease, except that (i)
compensation which shall have accrued to the date of death, including accrued Base
Salary, and other employee benefits to which Executive is entitled upon his death,
shall be paid or provided in accordance with the terms of the plans and programs of
CME, (ii) all stock option, SAR, time-vesting restricted stock and time vesting
restricted stock unit awards granted after August 5, 2009, will become fully vested
(and in the case of option and SAR awards shall remain exercisable for 48 months
following termination (but not beyond the maximum term of the award)) and (iii) all
equity or equity-based awards the vesting of which is contingent upon the attainment of
performance goals shall vest at target level of performance and become payable within
thirty (30) days following the date of death.

	 	(b)	 	Disability. Employer may, at its option, terminate this Agreement upon
written notice to Executive if Executive, because of physical or mental incapacity or
disability, fails to perform the essential functions of his position required of him
hereunder for a continuous period of 90 days or any 120 days within any 12-month
period. Upon such termination, all obligations of Employer hereunder shall cease,
except that (i) compensation which shall have accrued to the date of disability,
including accrued Base Salary, and other employee benefits to which Executive is
entitled upon his disability, shall be paid or provided in accordance with the terms of
the plans and programs of CME, (ii) all stock option, SAR, time-vesting restricted
stock and time-vesting restricted stock unit awards granted after August 5, 2009 will
become fully vested (and in the case of option and SAR awards shall remain exercisable
for 48 months following termination (but not beyond the maximum term of the award)),
(iii) all equity or equity-based awards the vesting of which is contingent upon the
attainment of performance goals shall vest at target level of performance and become
payable within thirty (30) days following the date of such termination of employment;
and (iv) Executive shall be entitled to the medical benefits described in Section 7(f).
In the event of any dispute regarding the existence of Executive’s disability
hereunder, the matter shall be resolved by a majority of the independent directors on
the Board.

	 	(c)	 	Cause. Employer may, at its option, terminate Executive’s employment
under this Agreement for Cause. As used in this Agreement, the term “Cause” shall mean
any one or more of the following:

	 	(1)	 	any refusal by Executive to perform his duties and
responsibilities under this Agreement, as determined after investigation by the
Board. Executive, after having been given written notice by Employer, shall
have seven (7) days to cure such refusal;

	 	(2)	 	any intentional act of fraud, embezzlement, theft or
misappropriation of Employer’s funds by Executive, as determined after
investigation by the Board, or Executive’s admission or conviction of a felony
or of any crime involving moral turpitude, fraud, embezzlement, theft or
misrepresentation;

	 	(3)	 	any gross negligence or willful misconduct of Executive
resulting in a financial loss or liability to the Employer or damage to the
reputation of Employer, as determined after investigation by the Board;

	 	(4)	 	any breach by Executive of any one or more of the covenants
contained in Section 8, 9 or 10 hereof;

	 	(5)	 	any violation of any rule, regulation or guideline imposed by
CME or a regulatory or self regulatory body having jurisdiction over Employer,
as determined after investigation by the Board.

The exercise of the right of CME to terminate this Agreement pursuant to this
Section 7(c) shall not abrogate any other rights or remedies of CME in respect of
the breach giving rise to such termination.

If Employer terminates Executive’s employment for Cause, Executive shall be entitled
to accrued Base Salary through the date of the termination of his employment, other
employee benefits to which Executive is entitled upon his termination of employment
with Employer, in accordance with the terms of the plans and programs of CME. Upon
termination for Cause, Executive will forfeit any unvested or unearned compensation
and long-term incentives, unless otherwise specified in the terms of the plans and
programs of CME.

	 	(d)	 	Termination Without Cause. Upon 30 days prior written notice to
Executive, the Board of Directors, by vote of a majority of the independent directors
may terminate this Agreement for any reason other than a reason set forth in paragraphs
(a), (b) or (c) of this Section 7. If, during the Agreement Term, the employment of
Executive hereunder is terminated by Employer for any reason other than a reason set
forth in subsections (a), (b) or (c) of this Section 7:

	 	(1)	 	Executive shall be entitled to receive accrued Base Salary
through the date of the termination of his employment, and other employee
benefits to which Executive is entitled upon his termination of employment with
Employer, in accordance with the terms of the plans and programs of Employer;

	 	(2)	 	subject to Executive’s execution and delivery prior to the
Release Deadline (as defined below) of a general release in a form and of a
substance satisfactory to Employer, Executive shall be entitled to receive a
one time lump sum severance payment equal to two times Executive’s annual Base
Salary, which shall be paid within 14 days of the later of the delivery of such
general release to Employer or the date on which such general release becomes
irrevocable. For purposes hereof, the “Release Deadline” means the deadline
prescribed by Employer for the execution of the general release described in
this paragraph (d)(2) of Section 7, which deadline shall in no event be later
than 60 days following the date Executive’s employment terminates;

	 	(3)	 	subject to Executive’s execution and delivery prior to the
Release Deadline (as defined below) of a general release in a form and of a
substance satisfactory to Employer, (i) all stock option, SAR, time-vesting
restricted stock and time-vesting restricted stock unit awards granted after
August 5, 2009 shall become fully vested (and in the case of option and SAR
awards shall remain exercisable for 48 months following termination (but not
beyond the maximum term of the award)) and (ii) all equity or equity-based
awards the vesting of which is contingent upon the attainment of performance
goals shall have the continued employment requirement applicable to such award
waived and shall become vested or shall be forfeited solely based on actual
performance measured over the full performance term; and

	 	(4)	 	Executive shall be entitled to the medical benefits described
in Section 7(f).

1

	 	(e)	 	Voluntary Termination.

	 	(1)	 	Upon 90 days prior written notice to CME (or such shorter
period as may be permitted by CME), Executive may voluntarily terminate his
employment with CME prior to the end of the Agreement Term for any reason. If
Executive voluntarily terminates his employment pursuant to this subsection
(e), he shall be entitled to receive accrued Base Salary through the date of
the termination of his employment and other employee benefits to which
Executive is entitled upon his termination of employment with CME, in
accordance with the terms of the plans and programs of CME.

	 	(2)	 	In addition, if Executive voluntarily terminates his employment
during the Agreement Term within the 30 day period immediately following a
material diminution of Executive’s title, duties, power or authority without
Executive’s written consent, then such termination of employment will be
treated as a termination of employment without Cause under Section 7(d) hereof.

	 	(f)	 	Upon a termination of Executive’s employment described in Section 7(b), 7(d),
7(e) or 7(h), Executive shall be entitled to elect to continue coverage for himself and
his eligible dependents, for up to 48 months following employment termination, under
the medical and dental plans of Employer in which Executive was participating
immediately prior to such employment termination. Executive’s monthly cost for such
coverage shall be (i) the applicable COBRA premium for such coverage (which cost shall
be applicable during the eighteen (18) month period following termination) and (ii) the
monthly premium cost paid by Employer for Executive’s coverage (which cost shall be
applicable following expiration of the 18 month COBRA period). Upon or prior to the
commencement of each 12 month period during the 48 month continuation period, Executive
shall inform Employer whether Executive elects to continue coverage in accordance with
this Section 7(f) for such 12 month period. In the event that Executive elects to
continue such coverage, Employer shall pay to Executive an amount, in a lump sum within
30 days following the commencement of such 12 month period, equal to 150% of
Executive’s total potential monthly cost for such coverage for such 12 month period
(based upon the rates in effect at the time of such election). No payment will be made
if (and to the extent) Executive does not elect to continue coverage. Notwithstanding
the foregoing timing requirements, with respect to the initial 12 month period, payment
of the lump sum amounts payable under this Section 7(f) up to the maximum amount
allowed for de minimis payments under IRS Code Section 409A (“Section 409A”) shall be
paid within fourteen (14) days of termination of Executive’s employment. The remainder
of the lump sum amounts with respect to the first 12 month period, if any, shall be
paid six (6) months after the date Executive terminates employment. Notwithstanding
anything in this Section 7(f) to the contrary, Executive’s continued coverage under
such plans shall end upon the date, if any, when Executive obtains comparable coverage
(as compared to the coverage provided under the applicable plans of Employer) from a
subsequent employer of Executive or Executive’s spouse.

	 	(g)	 	All awards of options and shares granted prior to August 5, 2009 shall be
governed by the terms and conditions of such awards at the time of grant.

	 	(h)	 	Notwithstanding any other provision of this Agreement, if Executive is employed
by Employer on December 31, 2016 then, subject to Executive’s execution and delivery
prior to December 31, 2016 of a general release in a form and of a substance
satisfactory to Employer, all then-outstanding equity or equity-based awards granted
after August 5, 2009 and prior to the Effective Date shall be treated in the manner
described in clauses (3)(i) and (3)(ii) of Section 7(d) (as applicable) except to the
extent that the application of such treatment would result in the imposition of tax on
an Executive pursuant to IRS Code Section 409A (in which case such treatment will occur
upon the earliest date which will not result in the imposition of such tax). Executive
acknowledges that the application of this Section 7(h) may result in the imposition of
taxes on Executive with respect to equity or equity-based awards at the time of vesting
and agrees to pay to Employer any withholding amounts with respect to such awards at
the time determined by the Employer. In addition, if Executive is employed by Employer
on December 31, 2016 and his employment terminates on or after December 31, 2016 other
than for any reason set forth in the definition of Cause under Section 7(c) hereof,
Executive shall be entitled following such termination to the medical benefits
described in Section 7(f).

Furthermore, notwithstanding any other provision of this Agreement, if Executive is
employed by Employer on December 31, 2019 then, subject to Executive’s execution and
delivery prior to December 31, 2019 of a general release in a form and of a
substance satisfactory to Employer, all then-outstanding equity or equity-based
awards granted after the Effective Date shall be treated in the manner described in
clauses (3)(i) and (3)(ii) of Section 7(d) (as applicable) except to the extent that
application of such treatment would result in the imposition of tax on Executive
pursuant to IRS Code Section 409A (in which case such treatment will occur upon the
earliest date which will not result in the imposition of such tax). Executive
acknowledges that the application of this Section 7(h) may result in the imposition
of taxes on Executive with respect to equity or equity-based awards at the time of
vesting and agrees to pay Employer any withholding amounts with respect to such
awards at the time determined by the Employer.

2

	 	8.	 	Confidential Information and Non-Compete. Executive acknowledges that
the successful development of CME’s services and products, including CME’s trading
programs and systems, current and potential customer and business relationships, and
business strategies and plans requires substantial time and expense. Such efforts
generate for CME valuable and proprietary information (“Confidential Information”)
which gives CME a business advantage over others who do not have such information.
Confidential information includes, but is not limited to the following: trade secrets,
technical, business, proprietary or financial information of CME not generally known to
the public, business plans, proposals, past and current prospect and customer lists,
trading methodologies, systems and programs, training materials, research data bases
and computer software; but shall not include information or ideas acquired by Executive
prior to his employment with CME if such pre-existing information is generally known in
the industry and is not proprietary to CME.

	 	(a)	 	Executive shall not at anytime during the Agreement Term or thereafter, make
use of or disclose, directly or indirectly to any competitor or potential competitor of
CME, or divulge, disclose or communicate to any person, firm, corporation, or other
legal entity in any manner whatsoever, or for his own benefit and that of any person or
entity other than Employer, any Confidential Information. This subsection shall not
apply to the extent Executive is required to disclose Confidential Information to any
regulatory agency or as otherwise required by law; provided, however, that Executive
will promptly notify Employer if Executive is requested by any entity or person to
divulge Confidential Information, and will use his best efforts to ensure that Employer
has sufficient time to intervene and/or object to such disclosure or otherwise act to
protect its interests. Executive shall not disclose any Confidential Information while
any such objection is pending.

	 	(b)	 	Executive agrees that during the Agreement Term and for a period of one (1)
year following the termination of Executive’s employment with CME for any reason,
Executive shall not (i) be employed in an executive or managerial capacity by, or (ii)
provide, whether as an employee, partner, independent contractor, consultant or
otherwise, any services of an executive or managerial nature, or any services similar
to those provided by Executive to CME or any subsidiary or affiliate company (any such
entity, a “CME Group entity”) during Executive’s employment with any CME Group entity,
to any Competing Business. For the purposes of this Agreement, “Competing Business”
shall mean any business that is engaged in the same business or businesses of any CME
Group entity (including any prospective business in which any CME Group entity is
planning to engage). Executive acknowledges and agrees that the restrictions contained
in this Section 8(b) are reasonable and necessary to protect CME’s legitimate interests
in its customer and employee relationships, goodwill and Confidential Information.

	 	(c)	 	Upon termination for any reason, Executive shall return to Employer all
records, memoranda, notes, plans, reports, computer tapes and equipment, software and
other documents or data which constitute Confidential Information which he may then
possess or have under his control (together with all copies thereof) and all credit
cards, keys and other materials and equipment which are Employer’s property that he has
in his possession or control.

	 	(d)	 	If, at any time of enforcement of this Section 8, a court holds that the
restrictions stated herein are unreasonable, the parties hereto agree that a maximum
period, scope or geographical area reasonable under the circumstances shall be
substituted for the stated period, scope or area and that the court shall be allowed to
revise the restrictions contained herein to cover the maximum period, scope and area
permitted by law.

	9.	 	Non-solicitation.

	 	(a)	 	General. Executive acknowledges that Employer invests in recruiting
and training, and shares Confidential Information with, its employees. As a result,
Executive acknowledges that Employer’s employees are of special, unique and
extraordinary value to Employer.

	 	(b)	 	Non-solicitation. Executive further agrees that for a period of one
(1) year following the termination of his employment with CME for any reason he shall
not in any manner, directly or indirectly, induce or attempt to induce any employee of
CME to terminate or abandon his or her employment with CME for any purpose whatsoever.

	 	(c)	 	Reformation. If, at any time of enforcement of this Section 9, a court
holds that the restrictions stated herein are unreasonable, the parties hereto agree
that the maximum period, scope or geographical area reasonable under the circumstances
shall be substituted for the stated period, scope or area and that the court shall be
allowed to revise the restrictions contained herein to cover the maximum period, scope
and area permitted by law.

	10.	 	Intellectual Property. During the Agreement Term, Executive shall disclose to CME
and treat as confidential information all ideas, methodologies, product and technology
applications that he develops during the course of his employment with CME that relates
directly or indirectly to CME’s business. Executive hereby assigns to CME his entire right,
title and interest in and to all discoveries and improvements, patentable or otherwise, trade
secrets and ideas, writings and copyrightable material, which may be conceived by Executive or
developed or acquired by him during his employment with CME, which may pertain directly or
indirectly to the business of the CME. Executive shall at any time during or after the
Agreement Term, upon CME’s request, execute, acknowledge and deliver to CME all instruments
and do all other acts which are necessary or desirable to enable CME to file and prosecute
applications for, and to acquire, maintain and enforce, all patents, trademarks and copyrights
in all countries with respect to intellectual property developed or which was being developed
during Executive’s employment with CME.

	11.	 	Remedies. Executive agrees that given the nature of CME’s business, the scope and
duration of the restrictions in paragraphs 8, 9 and 10 are reasonable and necessary to protect
the legitimate business interests of CME and do not unduly interfere with Executive’s career
or economic pursuits. Executive recognizes and agrees that a breach of any or all of the
provisions of Sections 8, 9 and 10 will constitute immediate and irreparable harm to CME’s
business advantage, for which damages cannot be readily calculated and for which damages are
an inadequate remedy. Accordingly, Executive acknowledges that CME shall therefore be
entitled to seek an injunction or injunctions to prevent any breach or threatened breach of
any such section. Such injunctive relief shall not be Employer’s sole remedy. Executive
agrees to reimburse CME for all costs and expenses, including reasonable attorney’s fees and
costs, incurred by CME in connection with the successful enforcement of its rights under
Sections 8, 9 and 10 of this Agreement.

	12.	 	Survival. Sections 7(h), 8, 9, 10, 11 and 13 of this Agreement (and, as applicable,
the provisions referenced herein) shall survive and continue in full force and effect in
accordance with their respective terms, notwithstanding any termination of the Agreement.

	13.	 	Arbitration. Except with respect to Sections 8, 9 and 10, any dispute or controversy
between CME and Executive, whether arising out of or relating to this Agreement, the breach of
this Agreement, or otherwise, shall be settled by arbitration in Chicago, Illinois, in
accordance with the following:

	 	(a)	 	Arbitration hearings will be conducted by the American Arbitration Association
(AAA). Except as modified herein, arbitration hearings will be conducted in accordance
with AAA’s rules.

	 	(b)	 	State and federal laws contain statutes of limitation which prescribe the time
frames within which parties must file a law suit to have their disputes resolved
through the court system. These same statutes of limitation will apply in determining
the time frame during which the parties must file a request for arbitration.

	 	(c)	 	If Executive seeks arbitration, Executive shall submit a filing fee to the AAA
in an amount equal to the lesser of the filing fee charged in the state or federal
court in Chicago, Illinois. The AAA will bill Employer for the balance of the filing
and arbitrator’s fees.

	 	(d)	 	The arbitrator shall have the same authority to award (and shall be limited to
awarding) any remedy or relief that a court of competent jurisdiction could award,
including compensatory damages, attorney fees, punitive damages and reinstatement.
Employer and Executive may be represented by legal counsel or any other individual at
their own expense during an arbitration hearing.

	 	(e)	 	Judgment on the award rendered by the arbitrator may be entered in any court
having jurisdiction thereof.

	 	(f)	 	Except as necessary in court proceedings to enforce this arbitration provision
or an award rendered hereunder, or to obtain interim relief, neither a party nor an
arbitrator may disclose the existence, content or results of any arbitration hereunder
without the prior written consent of CME and Executive.

	14.	 	Notices. All notices and other communications required or permitted hereunder shall
be in writing and shall be deemed given when (i) delivered personally or by overnight courier
to the following address of the other party hereto (or such other address for such party as
shall be specified by notice given pursuant to this Section) or (ii) sent by facsimile to the
following facsimile number of the other party hereto (or such other facsimile number for such
party as shall be specified by notice given pursuant to this Section), with the confirmatory
copy delivered by overnight courier to the address of such party pursuant to this Section 14:

If to CME, to:

Terrence Duffy

Executive Chairman and President

CME Group Inc.

20 South Wacker Drive

Chicago, IL 60606

(312) 930-3100

With a copy to:

Kathleen M. Cronin

Managing Director, General Counsel and Corporate Secretary

CME Group Inc.

20 South Wacker Drive

Chicago, IL 60606

(312) 930-3488

If to Executive, to:

Phupinder Gill

[redacted]

	15.	 	Severability. Whenever possible, each provision of this Agreement shall be
interpreted in such manner as to be effective and valid under applicable law, but if any
provision of this Agreement is held to be invalid, illegal or unenforceable in any respect
under applicable law or rule in any jurisdiction, such invalidity, illegality or
unenforceability shall not affect the validity, legality or enforceability of any other
provision of this Agreement or the validity, legality or enforceability of such provision in
any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such
jurisdiction as if such invalid, illegal or unenforceable provision had never been contained
herein.

	16.	 	Entire Agreement. This Agreement constitutes the entire Agreement and understanding
between the parties with respect to the subject matter hereof and supersedes and preempts any
prior understandings, agreements or representations by or between the parties, written or
oral, which may have related in any manner to the subject matter hereof, including, without
limitation, the Amended and Restated Agreement, effective as of August 5, 2009, as amended as
of April 6, 2011, and the Agreement effective as of April 18, 2012, and the Agreement
effective as of February 5, 2014 (the “Predecessor Agreements”). No other agreement or
amendment to this Agreement shall be binding upon either party including, without limitation,
any agreement or amendment made hereafter unless in writing, signed by both parties.
Executive acknowledges that each of the parties has participated in the preparation of this
Agreement and for purposes of principles of law governing the construction of the terms of
this Agreement, no party shall be deemed to be the drafter of the same.

	17.	 	Successors and Assigns. This Agreement shall be enforceable by Executive and his
heirs, executors, administrators and legal representatives, and by CME and its successors and
assigns.

	18.	 	Governing Law. This Agreement shall be governed by and construed and enforced in
accordance with the laws of the State of Illinois without regard to principles of conflict of
laws.

	19.	 	Acknowledgment. Executive acknowledges that he has read, understood, and accepts the
provisions of this Agreement.

	20.	 	IRS Code Section 409A. The intent of the parties is that payments and benefits under
this Agreement comply with Section 409A, to the extent subject thereto, and accordingly, to
the maximum extent permitted, this Agreement shall be interpreted and administered to be in
compliance therewith. Notwithstanding anything contained herein to the contrary, Executive
shall not be considered to have terminated employment with Employer for purposes of any
payments under this Agreement which are subject to Section 409A until Executive would be
considered to have incurred a “separation from service” from Employer within the meaning of
Section 409A. Each amount to be paid or benefit to be provided under this Agreement shall be
construed as a separate identified payment for purposes of Section 409A, and any payments
described in this Agreement that are due within the “short term deferral period” as defined in
Section 409A shall not be treated as deferred compensation unless applicable law requires
otherwise. Without limiting the foregoing and notwithstanding anything contained herein to
the contrary, to the extent required in order to avoid accelerated taxation and/or tax
penalties under Section 409A, amounts that would otherwise be payable and benefits that would
otherwise be provided pursuant to this Agreement during the six-month period immediately
following Executive’s separation from service shall instead be paid on the first business day
after the date that is six months following Executive’s separation from service (or, if
earlier, Executive’s death). To the extent required to avoid accelerated taxation and/or tax
penalties under Section 409A, amounts reimbursable to Executive under this Agreement shall be
paid to Executive on or before the last day of the year following the year in which the
expense was incurred and the amount of expenses eligible for reimbursement (and in-kind
benefits provided to Executive) during any one year may not effect amounts reimbursable or
provided in any subsequent year.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 
	CME Group Inc.

By: /s/ Larry Gerdes

	 	Phupinder Gill

/s/ Phupinder Gill
	 

	 	

	Larry Gerdes

Chairman, Compensation Committee

	 	

	
 
	 	 

3EX-10.1

 Exhibit 10.1 

FIRST AMENDMENT AND WAIVER TO 

SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT 

This First Amendment and Waiver to Second Amended and Restated Loan and Security Agreement (this “Amendment”), is dated as of
November 3, 2015 by and among HERCULES TECHNOLOGY GROWTH CAPITAL, INC., a Maryland corporation (the “Borrower”), the several financial institutions party to the Loan Agreement (as defined below) as lenders (the
“Lenders”), and MUFG UNION BANK, N.A. (formerly Union Bank, N.A.), as a Lender and as agent for the Lenders (in such capacity, the “Agent”). 

BACKGROUND 
 A.
Borrower, the Lenders and Agent are parties to the Second Amended and Restated Loan and Security Agreement, dated as of August 14, 2014 (collectively, the “Loan Agreement”), pursuant to which the Lenders have agreed, subject to
and on the terms and conditions set forth therein, to make certain loans and other credit accommodations to or for the benefit of Borrower. 

B. Borrower has notified Agent and Lender that, prior to the date hereof, certain Events of Default have occurred that are continuing resulting
from the following (collectively, the “Existing Defaults”): (i) Borrower’s violation of Section 3.6 by failing to notify Agent promptly of the establishment of the accounts listed on
Schedule 3.6 hereto; (ii) Borrower’s violation of Section 3.8 by failing to notify Agent promptly of the formation of two Special Purpose Subsidiaries, namely, Hercules Capital Funding 2014-1 LLC in September
of 2014 and Hercules Capital Funding Trust 2014-1 in October of 2014; (iii) Borrower’s violation of Section 3.17 by failing to provide the required evidences of insurance during the period from the Closing Date through the date
of this Amendment; (iv) Borrower’s violation of Section 3.29 by failing to deliver to Agent promptly copies of the Material Agreements listed on Schedule 3.29 hereto; (v) Borrower’s violation of
Section 3.8, Section 4.1, Section 4.6 or any other provision with respect to certain transactions occurring prior to the date hereof that have been disclosed to Agent or in the publicly-available quarterly and
annual reports filed by Borrower; (vi) Borrower’s violation of Section 4.2 by failing to deliver to Agent a copy of its September, 2014 update to its Credit Policy and obtain the required consent thereto;
(vii) Borrower’s violation of Section 4.8 by, among other things, failing to satisfy each of the Specified Event Conditions in connection with certain payments or distributions occurring prior to the date hereof, in respect of
Notes Indebtedness which payments and distributions have been disclosed in writing to Agent prior to the date hereof; (viii) Borrower’s violation of Section 4.17 by, among other things, failing to satisfy each of the Specified
Event Conditions in connection with certain prepayments, defeasances, redemptions, repurchases, calls or other retirements, occurring prior to the date hereof, in respect of Notes Indebtedness which events have been disclosed in writing to Agent
prior to the date hereof; (ix) Borrower’s violation of Section 5.1 by failing to deliver to Agent, from the Closing Date through the date hereof, the reports, certificates, financial statements and other items as and when
required under Section 5.1(a) through Section 5.1(e), Section 5.1(g) and Section 5.1(h); and (x) the taking of any action, or the failure to take any action, when a Default or Event of Default has
occurred and is continuing, the failure to give notice of such Default or Event of Default, or the taking of any action without delivering any required notices, documents or information. 

C. Borrower has requested that Agent and Lender agree to waive certain Existing Defaults and amend certain provisions of the Loan Agreement.
While it is under no obligation to do so, MUFG Union Bank, as Agent and a Lender, is willing to waive the Existing Defaults and to amend the Loan Agreement on the terms and subject to the conditions set forth herein. 

 AGREEMENT 

Now therefore, for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties to this Amendment,
intending to be legally bound, hereby agree as follows: 
 1. Incorporation of Recitals: Definitions. Each of the above recitals is
incorporated herein as true and correct and is relied upon by the Agent and each Lender in agreeing to the terms of this Amendment. Any capitalized term used but not defined herein shall have the meaning ascribed thereto in the Loan Agreement. 

2. Representations and Warranties. Borrower represents and warrants to, and covenants and agrees for the benefit of, the Agent and each
Lender that: 
 a. after taking into account the waivers and consents provided hereunder, the representations and warranties of Borrower set
forth in the Loan Agreement and each other Loan Document were true, correct and complete as of the date originally made, and are true, correct and complete in all material respects as of the date hereof (except to the extent such representations and
warranties expressly refer to an earlier date, in which case they are true, correct and complete in all material respects as of such earlier date); provided that the foregoing materiality qualifications shall not apply to any representations or
warranties that are qualified by materiality in the text thereof, which representations and warranties shall be true in all respects; 
 b.
Borrower has the authority to execute this Amendment and the execution, delivery, and performance by Borrower of this Amendment and the other documents, instruments and agreements delivered or to be delivered in connection herewith (i) are
within the corporate powers of Borrower and have been duly authorized by all necessary corporate action on the part of Borrower, (ii) do not require any governmental or third party consents, except those which have been duly obtained and are in
full force and effect, (iii) do not and will not conflict with any Applicable Law or Borrower’s articles of incorporation, bylaws, minutes or resolutions, (iv) after giving effect to this Amendment, do not result in any breach of or
constitute a default under any agreement or instrument to which Borrower or any of its Subsidiaries is a party or by which they or any of their respective properties are bound, and (v) do not result in or require the creation or imposition of
any mortgage, deed of trust, pledge, Lien, security interest or other charge or encumbrance of any nature upon any of the assets or properties of Borrower or any of its Subsidiaries; 

c. this Amendment and the other certificates, instruments, documents and agreements delivered or to be delivered by Borrower in connection
herewith have been duly executed and delivered by Borrower and constitute the legal, valid, and binding obligation of Borrower, enforceable against Borrower in accordance with their respective terms, except to the extent that (i) enforcement
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws of general application affecting the rights and remedies of creditors, (ii) enforcement may be subject to general principles of equity, and
(iii) the availability of the remedies of specific performance and injunctive relief may be subject to the discretion of the court before which any proceedings for such remedies may be brought; 

d. other than with respect to the Existing Defaults, no event has occurred or failed to occur, and after and as a result of giving effect to
this Amendment will occur, that is, or, with notice or lapse of time or both would constitute, a Default, an Event of Default, or a breach or failure of any condition under any Loan Document; 

  
 2 

 e. after and as a result of giving effect to this Amendment, Borrower has no offset, defense,
counterclaim, dispute or disagreement of any kind or nature whatsoever with respect to its liabilities, obligations and indebtedness arising under or in connection with the Loan Agreement or any of the other Loan Documents; 

f. Set forth on Schedule 3.6 is a listing, as of the date hereof (the “First Amendment Closing Date”), of all of
Borrower’s Deposit Accounts and securities accounts, including, with respect to each bank or securities intermediary (a) the name and address of such Person, and (b) the account numbers of the Deposit Accounts or securities accounts
maintained with such Person. 
 3. Amendments to Loan Agreement. 

a. Section 2.2(c) of the Loan Agreement is hereby amended and restated in its entirety to read as follows: 

(c) not less than two (2) Business Days prior to the proposed Drawdown Date for such Loan, (i) Borrower shall have
delivered to Agent: (A) an updated Borrowing Base Certificate, including an aged list of Eligible Notes Receivable, a detailed calculation of the Borrowing Base, and such supporting detail and documentation as Agent may reasonably request;
(B) a summary of the filing information (to the extent available) of all UCC financing statements indicating Borrower’s security interest in any collateral obtained in connection with any Pledged Loan Paper; (C) a completed checklist
for each Note Receivable included or to be included in the Borrowing Base; and (D) all other Required Asset Documents, and (ii) Borrower shall have taken the actions with respect to all agreements, instruments and documents relating to
assets included in the Borrowing Base as may be required hereunder or under the Possessory Collateral Agreement and the other Loan Documents; 

b. Section 3.18(b) of the Loan Agreement is hereby amended and restated in its entirety to read as follows: 

(b) such Note Receivable arose in the ordinary course of Borrower’s business from the lending of money to the related
Account Debtor and, if evidenced by a promissory note, is evidenced by a promissory note that has been duly authorized by the related Account Debtor, and that, together with the related Loan Paper, is in full force and effect; 

c. Section 3.18(j) of the Loan Agreement is hereby amended and restated in its entirety to read as follows: 

(j)(1) Borrower is free to pledge such Note Receivable and grant to Agent, for the ratable benefit of the Lenders, a security
interest in such Note Receivable and the related Loan Paper, together with the related Loan Paper and all rights relating thereto, without the obtaining of consent of any Person, including the applicable Account Debtor or any agent with respect to
such Note Receivable; and (2) Borrower is free to assign and transfer such Note Receivable, together with the related Loan Paper and all rights relating thereto, without the obtaining of consent of any Person, including the applicable Account
Debtor or any agent with respect to such Note Receivable (except for (A) such consents which have been obtained prior to inclusion of such Note Receivable in the Borrowing Base and (B) customary restrictions on assignment and transfer
(applicable so long as no defined event of default exists under the underlying Loan Paper) 

  
 3 

 
to (i) competitors of the applicable Account Debtor; (ii) any Person acting in the capacity of, or for the benefit of, a vulture fund or distressed debt purchaser, and
(iii) non-U.S. Persons; provided that such restrictions are disclosed in writing to Agent); 
 d.
Section 3.18(m) of the Loan Agreement is hereby amended and restated in its entirety to read as follows: 
 (m)
if an Instrument has been issued in connection therewith, there is not more than one original of such Instrument representing all or any portion of such Note Receivable, and the original of such Instrument (if any) has been delivered to Agent or the
Pledgeholder, duly endorsed as Collateral; 
 e. Section 3.22(c) of the Loan Agreement is hereby amended and
restated in its entirety to read as follows: 
 (c) If Borrower is or becomes the beneficiary of a letter of credit relating
to any Pledged Loan Paper or Pledged Note Receivable, Borrower shall promptly, and in any event within two (2) Business Days after becoming a beneficiary, notify Agent thereof and, upon request by Agent, enter into a tri-party agreement with
Agent and the issuer and/or confirmation bank with respect to Letter of Credit Rights assigning such Letter of Credit Rights to Agent and directing all payments thereunder to the Collection Account. 

f. Section 3.23 of the Loan Agreement is hereby amended and restated in its entirety to read as follows: 

3.23 Collections and Proceeds of Collateral. 

(a) Borrower shall open and shall at all times maintain the Collection Account and the Custodial Account with Bank. All cash,
checks, drafts or other items of payment relating to or constituting payments made in respect of any or all of the Collateral, all Collections, and all other Proceeds of the Collateral, shall be deposited directly into the Collection Account.
Borrower shall maintain in effect at all times either (i) instructions to all Account Debtors on Pledged Notes Receivable to: (A) make payment of any obligations owing to Borrower directly, by ACH transfer or wire transfer, to the
Collection Account, and (B) to mail or deliver all checks or other forms of payment for amounts owing to Borrower to a post office box or other address approved in writing by Agent, or (ii) enforceable authorizations from Account Debtors
permitting Borrower to automatically debit payments in respect of all Pledged Notes Receivable directly from such Account Debtors’ deposit accounts through the Automated Clearing House (ACH) network or electronic funds transfers. Borrower shall
cause all such items referenced in the preceding sentence to be credited directly to the Collection Account. Borrower shall cause the entire balance in the Collection Account to be swept daily, or with such other frequency as Agent may approve, to
the Custodial Account. Other than such transfers to the Custodial Account, neither Borrower nor any Person claiming through Borrower shall, or attempt to, withdraw or transfer any portion of the Collection Account, make payments from the Collection
Account or issue withdrawal, transfer delivery or other instructions with respect to the Collection Account. If Borrower or any of its Subsidiaries or Affiliates receives any payments on account of Pledged Notes Receivable, Pledged Loan Paper,
Collections or any other Collateral, then Borrower shall hold or cause its Subsidiaries and Affiliates to hold such payments in trust for Agent and shall immediately deposit or cause its Subsidiaries to deposit all such payments, to the extent of
Borrower’s rights therein, into the Collection Account. 

  
 4 

 (b) Following the occurrence and during the continuance of an Event of Default:
(i) Borrower shall not, and shall not attempt to, withdraw or transfer any portion of the Collection Account or the Custodial Account, or make payments from either such account or issue withdrawal, transfer, delivery or other instructions with
respect to such accounts, except as may be approved by Agent in writing; and (ii) Agent may apply all or any part of the amounts in the Collection Account, the Custodial Account or any other account of Borrower maintained with Bank or
otherwise, to the Obligations as provided in Section 7.4. 
 (c) Borrower shall keep the Collateral, all
Collections and all other Proceeds of the Collateral segregated and separate from its other assets and property, and Borrower shall not at any time comingle Collections on or Proceeds of Pledged Notes Receivable with Proceeds of Notes Receivable or
Accounts that are not Proceeds of Pledged Notes Receivable. Borrower shall at all times maintain in effect instructions to all Account Debtors on Notes Receivable that are not Pledged Notes Receivable to make payments to accounts other than the
Collection Account and to a physical address that is not associated with the Collection Account or the Custodial Account. 

(d) Borrower shall deposit into a Deposit Account that is subject to a perfected first-priority Agent’s Lien all amounts
advanced by Borrower into escrow and all amounts delivered to Borrower to be held in escrow, including, without limitation, insurance premiums and proceeds, taxes, and other funds delivered to Borrower to be held on behalf of any Account Debtor
under any Pledged Note Receivable. 
 g. Section 3.29 of the Loan Agreement is hereby amended and restated in its
entirety to read as follows: 
 3.29 Material Contracts. As of November 3, 2015, Schedule 3.29
is a true, correct, and complete listing of all Material Contracts of Borrower other than Loan Paper. Borrower will promptly provide Agent with a true, complete and correct copy of each Material Contract executed by Borrower (other than Loan Paper,
except to the extent required hereunder); 
 h. Section 3.32(b)(2) of the Loan Agreement is hereby amended and
restated in its entirety to read as follows: 
 (2) Payments to Cash Management Account. On or before the first date
on which any Note Receivable is included in the Borrowing Base, Borrower shall have either (a) instructed all Account Debtors to make all payments in respect of all Pledged Notes Receivable directly to the Collection Account or (b) shall
have obtained appropriate authorizations from such Account Debtors permitting Borrower to automatically debit payments in respect of all Pledged Notes Receivable directly from such Account Debtors’ deposit accounts through the Automated
Clearing House (ACH) network or electronic funds transfers (which automatic debits shall be deposited only into the Collection Account). 

  
 5 

 i. Section 3.32(b)(3) of the Loan Agreement is hereby amended and
restated in its entirety to read as follows: 
 (3) Adjustments. If (i) Borrower makes a deposit into the
Collection Account or the Custodial Account in respect of a Collection of a Pledged Note Receivable or a Recovery and such Collection was received by Borrower in the form of a check that is not honored for any reason or (ii) Borrower makes a
mistake with respect to the amount of any Collection or Recovery and deposits an amount that is less than or more than the actual amount of such Collection or Recovery, Borrower shall appropriately adjust the amount subsequently deposited into the
Collection Account or Custodial Account to reflect such dishonored check or mistake. Any payment to Agent or any Lender in respect of which a dishonored check is received shall be deemed not to have been paid. 

j. Section 3.32(c) of the Loan Agreement is hereby amended and restated in its entirety to read as follows: 

(c) Realization Upon Defaulted Loan Paper. Borrower will use its reasonable efforts to repossess or otherwise comparably
convert the ownership of any Account Debtor Collateral with respect to Defaulted Loan Paper in accordance with the Credit Policy and the Accepted Servicing Practices. Borrower will follow the practices and procedures set forth in the Credit Policy
in order to realize upon such Account Debtor Collateral. Any sale of Account Debtor Collateral shall be evidenced by a certificate of a Responsible Officer of Borrower delivered to Agent identifying the Defaulted Loan Paper and the Account Debtor
Collateral, setting forth the sale price of the Account Debtor Collateral and certifying that such sale price is the fair market value of such Account Debtor Collateral; provided, that if after giving effect to such sale (a) the Net Borrowing
Availability would not be greater than or equal to zero or (b) a Default or an Event of Default would exist, then Borrower prior to selling any Account Debtor Collateral with respect to Defaulted Loan Paper shall obtain the prior written
consent of Agent. Borrower will remit to the Collection Account the Recoveries received in connection with the sale or disposition of Account Debtor Collateral with respect to Defaulted Loan Paper. 

k. Section 4.4(b) of the Loan Agreement is hereby amended and restated in its entirety to read as follows: 

(b) Amend any of its articles of incorporation or bylaws in a manner that would materially adversely affect Agent or the
Lenders; provided that Borrower may increase the number shares of its authorized capital stock so long as no Change of Control has occurred or would exist as a result thereof. 

l. Section 4.7 of the Loan Agreement is hereby amended by deleting the proviso after clause (c) thereof and
replacing it with the following: 
 “; provided that the restrictions set forth in this clause (c) shall not prohibit or restrict
the obligations of Borrower, if any, or Hercules Funding II set forth in Section 7.6 of that certain Amended and Restated Loan and Security Agreement dated as of June 29, 2015 by and among Hercules Funding II LLC, Wells Fargo Capital
Finance, LLC as administrative agent and the lenders party thereto or Section 3.05 of the Wells Fargo Sale and Servicing Agreement (collectively, as the same may be amended, modified, supplemented, restated or renewed from time to time, the
“Wells Fargo Facility”).” 

  
 6 

 m. Section 4.8(b) of the Loan Agreement is hereby amended and
restated in its entirety to read as follows: 
 (b) so long as no Default or Event of Default shall have occurred and be
continuing, or would occur as a result thereof, and Agent and Lenders shall have received the financial statements required hereunder for the most recently completed fiscal month, make distributions to the holders of its Stock to the extent
permitted by Applicable Law; provided, however, that notwithstanding the existence of a Default or an Event of Default, the Borrower may pay cash dividends and make cash distributions in the ordinary course of business to its
shareholders, in an amount not to exceed its investment company taxable income, net tax-exempt interest and net capital gains that are required under Applicable Law to be distributed to its shareholders in order to maintain and preserve
Borrower’s RIC status and to avoid excise taxes imposed on RICs (a “RIC Distribution”) so long as: (i) all outstanding Obligations (other than contingent indemnification and expense reimbursement obligations) in respect of
the Loans (if any) have been fully-repaid, in cash, at least one (1) Business Day prior to the date of such RIC Distribution, (ii) no additional Loans have been requested on or after the date that is one (1) Business Day prior to the
date of such RIC Distribution, and (iii) no Obligations (other than contingent indemnification and expense reimbursement obligations) in respect of Loans are outstanding immediately prior to, or after giving effect to, such RIC Distribution;

 n. Section 4.11 of the Loan Agreement is hereby amended by deleting the word “and” immediately
before clause (ii) and adding the following at the end of the Section, “and (iii) ordinary course transactions otherwise permitted hereunder between the Borrower and any of its Special Purpose Subsidiaries.” 

o. Section 5.3 of the Loan Agreement is hereby amended and restated in its entirety to read as follows: 

5.3 Electronic Delivery. Quarterly and annual financial statement reports required to be delivered pursuant to
Sections 5.1 and 5.2 (to the extent any such documents are included in materials otherwise filed with the SEC and publicly available) may be delivered electronically and if so delivered, shall be deemed to have been delivered on
the date (i) on which Borrower posts such reports or provides a link thereto on Borrower’s website at www.htgc.com, or (ii) on which such reports are posted electronically on a website that each Lender and Agent have access to
(whether a commercial, third-party website or whether sponsored by Agent), if any, on Borrower’s behalf; provided, that: (a) Borrower shall deliver paper copies of such reports to Agent or any Lender who requests Borrower to deliver
such paper copies until written request to cease delivering paper copies is given by Agent or such Lender; (b) Borrower shall notify (which may be by facsimile or electronic mail) Agent and each Lender of the posting of any such reports and
immediately following such notification Borrower shall provide to Agent, by electronic mail, electronic versions (i.e., soft copies) of such reports; and (c) in each instance, Borrower shall, upon request by Agent, provide paper copies of the
Compliance Certificates and Borrowing Base Certificates required by Sections 5.1 to Agent. Except for such Compliance Certificates, Agent shall have no obligation to request the delivery of or to maintain copies of the reports referred
to above, and in any event shall have no responsibility to monitor compliance by Borrower with any such request for delivery, and each Lender shall be solely responsible for requesting delivery to it or maintaining its copies of such reports. 

  
 7 

 p. Section 5.4 of the Loan Agreement is hereby deleted in its
entirety. 
 q. Section 6.1(b) of the Loan Agreement is hereby amended and restated in its entirety to read as
follows: 
 (b) Borrower shall defend the right, title and interest of Agent, for the benefit of Agent and the Lenders, in
and to the Collateral against the claims and demands of all Persons whomsoever, and shall take such actions, including (i) all actions necessary to grant Agent “control” of any Investment Property, Deposit Accounts, Letter of Credit
Rights or electronic Chattel Paper owned by Borrower included in the Collateral, with any agreements establishing control to be in form and substance reasonably satisfactory to Agent, (ii) the delivery to Pledgeholder, as agent for Agent of all
original Instruments, Chattel Paper, negotiable Documents and certificated Stock owned by Borrower included in the Collateral (in each case, accompanied by stock powers, allonges or other instruments of transfer executed in blank) promptly after
Borrower receives same, (iii) after the occurrence and during the continuance of an Event of Default, notification of Agent’s interest in Collateral at Agent’s request, (iv) preparation and delivery of all applications and other
relevant actions to note the Lien of Agent, for the benefit of Agent and Lenders, on any certificate of title included in the Collateral, and (v) the institution of litigation against third parties as shall be prudent in order to protect and
preserve Borrower’s, Agent’s and Lenders’ respective and several interests in the Collateral. Borrower shall mark its Books and Records pertaining to the Collateral to evidence the Loan Documents and the Liens granted under the Loan
Documents. If Borrower retains possession of any original Chattel Paper or original Instruments included in the Collateral with Agent’s consent, then, upon the request of Agent, such Chattel Paper and Instruments (other than warrants) shall be
marked with the following legend: “THIS WRITING AND THE OBLIGATIONS EVIDENCED OR SECURED HEREBY ARE SUBJECT TO THE LIEN OF MUFG UNION BANK, N.A., AS AGENT.” Borrower shall promptly, and in any event within two (2) Business Days after
the same is acquired by it, notify Agent of any Commercial Tort Claim acquired by it relating or pertaining to any Collateral, and unless otherwise consented to by Agent, Borrower shall enter into a supplement to this Agreement (and the Loan
Documents) granting to Agent (for the benefit of Agent and Lenders) a Lien in such Commercial Tort Claim. 
 r.
Section 7.1(b) of the Loan Agreement is hereby amended by deleting the words “or Section 4” at the end of such section and replacing them with “Section 4, or Section 5”. 

s. Schedule A to the Loan Agreement is hereby amended by (i) deleting the defined terms “ACH
Account,” and “Operating Account”, and (ii) amending and restating, or adding, the following definitions to read as follows: 

“Collateral” means all of Borrower’s right title and interest in and to the following, wherever located
and whether now existing or hereafter created or acquired: (a) all Notes Receivable and all related Loan Paper identified on any Borrowing Base Certificate, Loan Request, or Loan Supplement now existing or hereafter acquired, including without
limitation any and all Notes Receivable and related Loan Paper now or 

  
 8 

 
hereafter financed through a Loan under this Agreement, (b) all Collections, (c) the Collection Account, the Custodial Account and all other deposit, investment and securities accounts
in which Collections are deposited; (d) any and all property described in Section 6.1(c), (e) all Account Debtor Collateral with respect to any asset described in clause (a), (f) all Accounts, deposits, Investment Property,
Instruments, Documents, letters of credit, Letter of Credit Rights, Supporting Obligations, Commercial Tort Claims, Goods, Books and Records, General Intangibles, Chattel Paper pertaining to any of the foregoing, and (g) all products, profits,
rents of, dividends and distributions on, accessions to, and all other Proceeds of the foregoing including any and all of the following to the extent constituting such Proceeds of the foregoing (whether now existing or hereafter acquired, tangible
or intangible, and whether owned by, consigned to, or held by, or under the care, custody or control of Borrower): all money, cash, cash equivalents, Accounts, Deposit Accounts, other bank, securities, investment, commodity and deposit accounts,
deposits, Investment Property, Inventory, Equipment, Fixtures, Goods, Chattel Paper, Documents, Loan Paper, Notes Receivable, Instruments, letters of credit, Letter of Credit Rights, Supporting Obligations, Commercial Tort Claims, Books and Records,
General Intangibles (including all Intellectual Property, Claims, Payment Intangibles, contract rights, rights under or in respect of Hedge Agreements, choses in action, and Software) regardless of whether the Collateral, or any portion of it, is
property as to which the UCC provides the perfection of a security interest, and all rights and remedies applicable to such property, but excluding in all events, Hazardous Materials. 

“Collection Account” means the Deposit Account designated in writing by Borrower and Agent as the Collection
Account for purposes of this Agreement in the name of Borrower maintained at Bank. The Collection Account shall initially be that certain account maintained with Bank identified on Schedule 3.6 as the Collection Account. 

“Custodial Account” means the account designated in writing by Borrower and Agent as the Custodial Account for
purposes of this Agreement in the name of Borrower maintained at Bank or such other bank trust account as designated in writing by Borrower with the consent of Agent. The Custodial Account shall initially be that certain account maintained with Bank
identified on Schedule 3.6 as the Custodial Account. 
 “Custody Agreement” means the Global Custody
Agreement (For Foreign and Domestic Securities), dated as of August 31, 2015, by and between Bank, as custodian, and Borrower, as amended, modified, supplemented or restated from time to time; it being understood and agreed that in connection
with the establishment of any Custodial Account, Borrower will enter into a new or supplemental Custody Agreement which shall require the consent of Agent. 

“Note Receivable” means a promissory note evidencing a commercial loan made by Borrower in accordance with
Borrower’s Credit Policy and secured by a Lien on property owned by the maker of such promissory note; provided, that if Borrower’s Credit Policy as in effect at the time that such loan is made or purchased by Borrower do not require the
execution of a promissory note and no promissory note is executed to evidence such loan, then the term “Note Receivable” means the obligation of the Account Debtor to repay such loan as evidenced by the agreements and documents evidencing
such loan. 

  
 9 

 “Permitted Dispositions” means (a) sales or other
dispositions of Equipment that is substantially worn, damaged, or obsolete in the ordinary course of business, (b) the use or transfer of money or Cash Equivalents in connection with Permitted Investments in a manner that is not prohibited by
the terms of this Agreement or the other Loan Documents, (c) the licensing, on a non-exclusive basis, of patents, trademarks, copyrights, and other intellectual property rights in the ordinary course of business, (d) sales of a Note
Receivable and related Loan Paper (other than Pledged Notes Receivable and Pledged Loan Paper) to and from Special Purpose Subsidiaries in the ordinary course of business, consistent with past practice, and without recourse to Borrower (other than
customary obligations to repurchase ineligible Notes Receivable from Special Purpose Subsidiaries on terms substantially similar to those set forth in Section 3.05 of the Wells Fargo Sale and Servicing Agreement), for fair consideration and
reasonably equivalent value; provided that in each case, the Specified Event Conditions have been satisfied with respect to such sale, (e) commercially reasonable sales, licenses, transfers, assignments and other dispositions of Account Debtor
Collateral repossessed or acquired by Borrower, in accordance with applicable law, in the ordinary course of business in connection with a foreclosure or similar proceeding following a default under the Note Receivable secured by such Account Debtor
Collateral, (f) so long as no Event of Default exists, sales or other dispositions in the ordinary course of business by Borrower and its Subsidiaries of equity securities (including warrants) in portfolio companies, (g) to the extent that
common stock in the Borrower constitutes an asset of Borrower, the sale and issuance of such common stock by Borrower, and (h) so long as no Event of Default exists, sales or other dispositions in the ordinary course of business by Borrower and
its Subsidiaries of other assets in an aggregate amount not to exceed $5,000,000 in any fiscal year. 
 “Required
Asset Documents” means each of the following with respect to any Note Receivable that Borrower seeks to qualify as an Eligible Note Receivable: 

(a) either (i) the original promissory note(s) (if any) evidencing such Note Receivable, duly executed by the applicable
Account Debtor as maker and payable to the order of Borrower, or (ii) the written certification that there are no promissory notes evidencing such Note Receivable, duly executed by a Responsible Officer of Borrower (provided, that if no
original promissory note is delivered with respect to any Note Receivable made by Borrower, then such failure shall be deemed to constitute a representation and warranty by Borrower that there are no promissory notes evidencing such Note Receivable
and the delivery of neither (i) nor (ii) shall be required); 
 (b) a file-stamped copy of the related UCC
financing statement(s) naming the applicable Account Debtor as the debtor and Borrower as secured party; 
 (c) the originals
of all Transaction Warrants (if any) issued to Borrower in connection with such Note Receivable; 
 (d) the originals of all
other agreements, documents, or instruments evidencing or securing such Note Receivable (other than, in the case of Syndicated Loan Paper, in which case the original promissory note (if any) and the original Transaction Warrant and a copy of such
Syndicated Loan Paper shall be sufficient); and 
 (e)(i) an original Assignment of Note with respect to each original
promissory note (if any) referred to in clause (a) above, executed by Borrower to the 

  
 10 

 
order of Agent or in blank, (ii) an original Loan Supplement with respect to such Note Receivable and the related Loan Paper, duly executed by Borrower in favor of Agent, (iii) an
original assignment of warrant or stock power with respect to each warrant referred to in clause (c) above, executed by Borrower in blank, and (iv) an original assignment with respect to all of Borrower’s rights under the documents
referred to in clause (d) above, executed by Borrower in blank. 
 “Responsible Officer” means any of
Manuel Henriquez, Andrew Olson, Ben Bang, Robert Lake, Mark Harris, or any other individual then serving as the Chief Executive Officer, Chief Financial Officer, Corporate Controller, Chief Credit Officer, or Chief Legal Officer of Borrower. 

“Wells Fargo Sale and Servicing Agreement” means that certain Amended and Restated Sale and Servicing
Agreement, dated as of June 29, 2015 and as amended, modified, supplemented, restated and renewed from time to time, by and among Hercules Funding II, Borrower, as originator and servicer, and Wells Fargo Capital Finance, LLC as Agent. 

t. Schedule A to the Loan Agreement is hereby amended by amending and restating clause (g) of the
definition of “Eligible Loan Paper” to read as follows: 
 “(g) Such Loan Paper contains terms, conditions,
representations, warranties, covenants and events of default that are customary for commercial loan transactions, including provisions providing, in the case of SBA-Related Loan Paper, for pro rata (based on the amount of funds advanced by each of
Borrower and the related SBA Affiliate to the Account Debtor pursuant to such Loan Paper) allocation to Borrower and the related SBA Affiliate of all payments from the Account Debtor and of all proceeds with respect to the disposition of the Account
Debtor Collateral;” 
 u. Schedules 3.2 through 4.7 of the Loan Agreement are hereby
amended and restated in their entirety and replaced with Schedules 3.2 through 4.7 attached hereto. 
 4.
Conditions Precedent. Borrower understands that this Amendment shall not be effective and shall have no force or effect until each of the following conditions precedent has been satisfied, or waived in writing by Agent (in Agent’s sole
discretion): 
  

	 	a.	Borrower shall have duly executed and delivered to Agent this Amendment; 

  

	 	b.	After taking into account the waivers and amendments provided hereunder, the representations and warranties of Borrower under the Loan Agreement, the other Loan Documents and this Amendment, as applicable, shall be true
and correct in all material respects as of the date hereof (except to the extent such representations and warranties expressly refer to an earlier date, in which case they are true, correct and complete in all material respects as of such earlier
date); provided that the foregoing materiality qualifications shall not apply to any representations or warranties that are qualified by materiality in the text thereof, which representations and warranties shall be true in all respects;

  

	 	c.	 Agent shall have received in immediately available funds, all out-of-pocket costs and expenses (including reasonable attorneys’ fees and costs)
incurred by Agent in connection with this Amendment and the transactions contemplated hereby and 

  
 11 

	 	
invoiced to Borrower prior to the date on which this Amendment is otherwise to become effective; provided that the failure to invoice any such amounts to Borrower prior to such date shall not
preclude Agent from seeking reimbursement of such amounts, or excuse Borrower from paying or reimbursing such amounts, following the effective date of this Amendment; and 

 

	 	d.	Agent shall have received such other documents, and completion of such other matters, as Agent may reasonably deem necessary or appropriate in connection with this Amendment. 

5. Limited Waiver. Subject to and on the terms and conditions set forth herein, Agent and the Lenders, hereby waive the Existing
Defaults; provided however, that such waiver: (a) applies only to the instance specified above and for the times stated, (b) is not a waiver of any subsequent breach of the same provision of the Loan Agreement or any other
Loan Document, and (c) shall not extend or apply to, and is not a waiver of any breach of, any other Default of Event of Default. Nothing herein constitutes a waiver, amendment or forbearance of Borrower’s obligation to pay the
Obligations, as and when due. This waiver is not a continuing waiver with respect to any Event of Default or any obligation that Borrower may have under the Loan Agreement or the other Loan Documents after the date hereof. Except as expressly set
forth above, Agent and Lenders do not waive any failure by Borrower to perform any obligation under the Loan Agreement or any other Loan Document. Agent and each Lender reserves all of their respective rights, powers and remedies available to them
under the Loan Documents and applicable law, including the right to cease making advances to Borrower and to accelerate any or all of Borrower’s indebtedness if any subsequent breach of the same provisions or any other provision of the Loan
Agreement or any other Loan Document should occur. Neither Agent nor any Lender is obligated to grant this or any other waiver, consent or loan modification. 

6. Ratification and Confirmation of Loan Documents. Except as expressly set forth in Section 3 hereof, the execution, delivery, and
performance of this Amendment shall not alter, modify, amend, or in any way affect any of the terms, conditions, obligations, covenants, or agreements contained in the Loan Agreement or any other Loan Document, and shall not operate as a waiver of
any right, power, or remedy of Agent or any Lender under the Loan Agreement or any other Loan Document. The Loan Agreement, all promissory notes, guaranties, security agreements, and all other instruments, documents and agreements entered into in
connection with the Loan Agreement and each other Loan Document shall be and remain in full force and effect in accordance with their respective terms and hereby are ratified and confirmed by Borrower in all respects. 

7. No Other Waivers. This Amendment: (a) in no way shall be deemed to imply a willingness on the part of Agent or any Lender to
grant any similar or other future waivers or to agree to any future consents, amendments or modifications to any of the terms and conditions of the Loan Agreement or the other Loan Documents; and (b) shall not in any way, prejudice, limit,
impair or otherwise affect any rights or remedies of Agent or any Lender under the Loan Agreement or any of the other Loan Documents, including, without limitation, Agent’s or any Lender’s right to demand strict performance of
Borrower’s liabilities and obligations to Agent and the Lenders and the Obligations under the Loan Documents at all times. Borrower acknowledges and agrees that Agent and each Lender is relying upon Borrower’s representations, warranties
and agreements, as set forth herein and in the other Loan Documents in entering into this Amendment. Nothing in this Amendment shall constitute a satisfaction of Borrower’s Obligations. 

8. Miscellaneous. Borrower acknowledges and agrees that the representations and warranties set forth herein are material inducements to
Agent and the Lenders to deliver this Amendment. This Amendment shall be binding upon and inure to the benefit of and be enforceable by the parties 

  
 12 

 
hereto, and their respective permitted successors and assigns. This Amendment and the Loan Agreement shall be read together as one document. No course of dealing on the part of Agent, the Lenders
or any of their respective officers, nor any failure or delay in the exercise of any right by Agent or the Lenders, shall operate as a waiver thereof, and any single or partial exercise of any such right shall not preclude any later exercise of any
such right. The failure at any time to require strict performance by Borrower of any provision of the Loan Documents shall not affect any right of Agent or the Lenders thereafter to demand strict compliance and performance. Any suspension or waiver
of a right must be in writing signed by an officer of Agent and/or the Lenders, as applicable. No other Person shall be entitled to claim any right or benefit hereunder, including, without limitation, the status of a third party beneficiary
hereunder. This Amendment shall be governed by and construed in accordance with the laws of the State of California without reference to conflicts of law rules. If any provision of this Amendment or any of the other Loan Documents shall be
determined by a court of competent jurisdiction to be invalid, illegal or unenforceable, that portion shall be deemed severed herefrom or therefrom, as applicable, and the remaining parts shall remain in full force as though the invalid, illegal or
unenforceable portion had never been a part hereof or thereof, as applicable. This Amendment may be executed in any number of counterparts, including by electronic or facsimile transmission, each of which when so delivered shall be deemed an
original, but all such counterparts taken together shall constitute but one and the same instrument. 
 [Signature Page
Follows] 

  
 13 

 IN WITNESS WHEREOF, Borrower, Agent and the Lenders have caused this Amendment to be executed as
of the date first written above. 
  

							
	 BORROWER:
	 		 	HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
				
		 		 	By:	 	/s/ Mark Harris
		 		 	Name:	 	Mark Harris
		 		 	Title:	 	Chief Financial Officer

 [Signature Page to First Amendment to 

Second Amended and Restated Loan and Security Agreement] 

 IN WITNESS WHEREOF, Borrower, Agent and the Lenders have caused this Amendment to be executed as
of the date first written above. 
  

							
	 AGENT:
	 		 	MUFG UNION BANK, N.A., as Agent
				
		 		 	By:	 	/s/ James B. Goudy
		 		 		 	James B. Goudy
		 		 	Title:	 	Director

  

							
	 LENDER:
	 		 	MUFG UNION BANK, N.A., as Lender
				
		 		 	By:	 	/s/ James B. Goudy
		 		 		 	James B. Goudy
		 		 	Title:	 	Director

 [Signature Page to First Amendment to 

Second Amended and Restated Loan and Security Agreement] 

 Schedule 3.2 

Executive Offices; Corporate or Other Names; Conduct of Business 

- Jurisdictions of Organization: 
  

					
	Entity Name	  	Type of Entity	  	Jurisdiction of Formation
	 Borrower
	  	 Corporation
	  	 Maryland

	 Hercules Funding II, LLC
	  	 Limited Liability Company
	  	 Delaware

	 Hercules Technology II, L.P.
	  	 Limited Partnership
	  	 Delaware

	 Hercules Technology III, L.P.
	  	 Limited Partnership
	  	 Delaware

	 Hercules Technology IV, L.P.
	  	 Limited Partnership
	  	 Delaware

	 Hercules Technology SBIC Management, LLC
	  	 Limited Liability Company
	  	 Delaware

	 Hydra Ventures, LLC
	  	 Limited Liability Company
	  	 Delaware

	 Hercules Technology Management Co. II Inc.
	  	 Corporation
	  	 Delaware

	 Hercules Technology Management Co. III Inc.
	  	 Corporation
	  	 Delaware

	 Hercules Technology Management Co. V Inc.
	  	 Corporation
	  	 Delaware

	 Hercules Technology I, LLC
	  	 Limited Liability Company
	  	 Delaware

	 Hercules Technology II, LLC
	  	 Limited Liability Company
	  	 Delaware

	 Hercules Capital Funding 2012-1 LLC
	  	 Limited Liability Company
	  	 Delaware

	 Hercules Capital Funding Trust 2012-1
	  	 Business Trust
	  	 Delaware

	 Hercules Capital Funding 2014-1 LLC
	  	 Limited Liability Company
	  	 Delaware

	 Hercules Capital Funding Trust 2014-1
	  	 Business Trust
	  	 Delaware

 - Locations of Collateral: 
  

			
	 400 Hamilton Avenue, Suite 310

Palo Alto, CA 94301
	  	777 Church Street
 Elmhurst, IL 60126

		  	
	 31 St. James Ave, Suite 790
	  	2500 Broadway
	 Boston, MA 02116
	  	Building F, Suite F-125
		  	Santa Monica, CA 90404
	 1600 Tysons Boulevard, 8th Floor
	  	
	 McLean, VA 22102
	  	100 Matsonford Road, Suite 410
		  	Radnor, PA 19087
	 100 Park Ave., 34th Floor
	  	
	 New York, NY 10017
	  	

 - Chief Executive Offices: 
  

	
	 400 Hamilton Avenue, Suite 310

	 Palo Alto, CA 94301

 - Organizational ID Numbers: 
  

					
	Entity Name	  	 Organizational
Identification

Number
	  	Federal
Employer
Identification
Number
	 Borrower
	  	D07705197	  	74-3113410
	 Hercules Funding II, LLC
	  	4582401	  	26-3212368
	 Hercules Technology II, L.P.
	  	3916747	  	11-3749573
	 Hercules Technology III, L.P.
	  	4728789	  	27-0924518
	 Hercules Technology IV, L.P.
	  	4917870	  	27-4334020
	 Hercules Technology SBIC Management, LLC
	  	3728003	  	11-3749567
	 Hydra Ventures, LLC
	  	4264926	  	20-8117315
	 Hercules Technology Management Co. II Inc.
	  	4531711	  	20-2386260
	 Hercules Technology Management Co. III Inc.
	  	4548181	  	26-2820058
	 Hercules Technology Management Co. V Inc.
	  	4548185	  	26-2820144
	 Hercules Technology I, LLC
	  	3727330	  	27-0521835
	 Hercules Technology II, LLC
	  	3916747	  	27-1451720
	 Hercules Capital Funding 2012-1 LLC
	  	5254633	  	46-2011652
	 Hercules Capital Funding Trust 2012-1

Hercules Capital Funding 2014-1 LLC

Hercules Capital Funding Trust 2014-1
	  	5255228
 5608455
 5614039
	  	38-7073621
 47-2024857

47-6539095

 Schedule 3.6 

Bank Accounts 
  

							
	 Account Holder
	  	 Bank
	  	Acct #	  	 Description

	Hercules Technology Growth Capital, Inc.	  	MUFG Union Bank, N.A.	  	6734307490	  	Custodial Account
	Hercules Technology Growth Capital, Inc.	  	MUFG Union Bank, N.A.	  	4720024751	  	Operating Account
	Hercules Technology Growth Capital, Inc.	  	MUFG Union Bank, N.A.	  	4720011889	  	Collection Account
	Hercules Technology Growth Capital, Inc.	  	MUFG Union Bank, N.A.	  	8580006141	  	Money Market
	Hercules Technology Growth Capital, Inc.	  	MUFG Union Bank, N.A.	  	4729010936	  	Time Deposit
	Hercules Technology Growth Capital, Inc.	  	Wells Fargo	  	412-4015488	  	Collection Account
	Hercules Technology Growth Capital, Inc.	  	Wells Fargo	  	412-4015470	  	Operating Account
	Hercules Technology Growth Capital, Inc.	  	Wells Fargo Custody	  	84270700	  	Custodial Account
	Hercules Technology Growth Capital, Inc.	  	JMP Securities	  	JMD-001051	  	Brokerage Account

 Schedule 3.7 

Employment Agreements 
 None. 

 Schedule 3.8 

Ventures, Subsidiaries and Affiliates; Outstanding Stock and Indebtedness 

- As of the First Amendment Closing Date, 72,072,409 shares of the Borrower’s common stock are outstanding at $0.001 par value. 

- As of the First Amendment Closing Date, there are no holders of 10% or more of the Borrower’s common stock 

- Borrower and Subsidiaries: 
  

							
	 	  	Jurisdiction
of
Formation	  	Number of
Shares of
Common and
Preferred Stock
Authorized	  	Percentage
owned by
Borrower
	 Borrower
	  	Maryland	  	200,000,000	  	
	 Hercules Funding II, LLC
	  	Delaware	  	unlimited	  	100%
	 Hercules Technology II, L.P.
	  	Delaware	  	unlimited	  	100%
	 Hercules Technology III, L.P.
	  	Delaware	  	unlimited	  	100%
	 Hercules Technology IV, L.P.
	  	Delaware	  	unlimited	  	100%
	 Hercules Technology SBIC Management, LLC
	  	Delaware	  	unlimited	  	100%
	 Hydra Ventures, LLC
	  	Delaware	  	unlimited	  	100%
	 Hercules Technology Management Co. II Inc.
	  	Delaware	  	100	  	100%
	 Hercules Technology Management Co. III Inc.
	  	Delaware	  	100	  	100%
	 Hercules Technology Management Co. V Inc.
	  	Delaware	  	100	  	100%
	 Hercules Technology I, LLC
	  	Delaware	  	100	  	100%
	 Hercules Technology II, LLC
	  	Delaware	  	100	  	100%
	 Hercules Capital Funding 2012-1 LLC
	  	Delaware	  	100	  	100%
	 Hercules Capital Funding Trust 2012-1
	  	Delaware	  	n/a	  	100%
	 Hercules Capital Funding 2014-1 LLC
	  	Delaware	  	100	  	100%
	 Hercules Capital Funding Trust 2014-1
	  	Delaware	  	n/a	  	100%

 Schedule 3.11 

Taxes 
 None 

 Schedule 3.12 

ERISA Plans 
 Borrower maintains a 401K
plan. 

 Schedule 3.13 

Litigation 
 None. 

 Schedule 3.14 

Intellectual Property 
  

					
	 Trademark
	  	Registration
Number	 
	 Name and Mark: “Hercules Technology Growth Capital, Inc.”
	  	 	3923289	  
	 Name and Mark: “Hercules Technology Growth Capital, Inc.”
	  	 	3923288	 

 Schedule 3.16 

Hazardous Materials 
 None. 

 Schedule 3.29 

Material Contracts 
 Lease Agreement, dated
as of June 13, 2006, between the Hercules Technology Growth Capital, Inc. and 400 Hamilton Associates. 
 Sale and Servicing Agreement by and Among
Hercules Capital Funding 2014-1 LLC, Hercules Capital Funding Trust 2014-1 LLC, Hercules Technology Growth Capital, Inc. and U.S. Bank National Association, dated as of November 13, 2014. 

Sale and Contribution Agreement by and between Hercules Technology Growth Capital, Inc. and Hercules Capital Funding 2014-1 LLC, dated as of November 13,
2014. 
 Note Purchase Agreement among the Hercules Technology Growth Capital, Inc., Hercules Capital Funding 2014-1 LLC, as Trust Depositor, Hercules
Capital Funding Trust 2014-1, as Issuer, and Guggenheim Securities, LLC, as Initial Purchaser, dated as of November 4, 2014. 
 Administration
Agreement between Hercules Capital Funding Trust 2014-1 LLC, Hercules Technology Growth Capital, Inc., Wilmington Trust, National Association, and U.S. Bank National Association, dated as of November 13, 2014. 

Indenture between Hercules Technology Growth Capital, Inc. and U.S. Bank National Association, dated as of April 15, 2011. 

Indenture between Hercules Technology Growth Capital, Inc. and U.S. Bank National Association, dated as of March 6, 2012. 

First Supplemental Indenture between Hercules Technology Growth Capital, Inc. and U.S. Bank National Association, dated as of April 17, 2012. 

Second Supplemental Indenture between Hercules Technology Growth Capital, Inc. and U.S. Bank National Association, dated as of September 24, 2012. 

Third Supplemental Indenture between Hercules Technology Growth Capital, Inc. and U.S. Bank National Association, dated as of July 14, 2014. 

Custodial Agreement between Hercules Technology Growth Capital, Inc. and Wells Fargo, National Association dated July 29, 2015. 

Global Custody Agreement between Hercules Technology Growth Capital, Inc. and MUFG Union Bank, N.A dated August 31, 2015. 

 Schedule 4.6(a) 

Notes Indebtedness 
  

	1.	$64,489,500 aggregate principal amount of 7.00% Senior Notes due April 2019 (CUSIP No. 427096888). 

  

	2.	$85,875,000 aggregate principal amount of 7.00% Senior Notes due September 2019 (CUSIP No. 427096870). 

  

	3.	$103,000,000 aggregate principal amount of 6.25% Notes due July, 2024 (CUSIP No. 427096862). 

  

	4.	$17,604,000 aggregate principal amount of 6.00% convertible senior notes due April 2016 (CUSIP No. 427096AA0). 

 Schedule 4.6(b) 

Permitted Special Purpose Indebtedness 
  

	1.	SBA debentures outstanding as of June 30, 2015 as identified in the Form 10-Q filed by the Borrower for the quarter ended June 30, 2015. 

 

	2.	Asset-backed notes issued by Hercules Capital Funding Trust 2014-1 pursuant to the note purchase agreement, dated as of November 4, 2014. 

 

	3.	Amended and Restated Loan and Security Agreement by and among Hercules Funding II LLC and Wells Fargo Capital Finance, LLC, dated as of June 29, 2015, as amended. 

 Schedule 4.7 

Permitted Liens 
 None.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00251-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00251-of-00352.parquet"}]]